Comparing Pregabalin and Lacosamide for Pain Relief in Shingles Patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of two medications, Pregabalin and Lacosamide, in treating post-herpetic neuralgia (PHN), a painful condition that can occur after shingles. The study involves patients aged 18 to 50 who have been diagnosed with herpes zoster and are experiencing PHN. Participants will receive either Pregabalin or Lacosamide to determine which medication provides better pain relief. The trial aims to address the often debilitating pain associated with PHN, which can significantly impact daily life and well-being.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosed cases of herpes zoster suffering from postherpetic neuralgia
* Ages: 18 to 50
* Both male and female

Exclusion Criteria:

* Lack of consent
* Patient already taking pain killers for post herpetic neuralgia
* Patients suffering from other systemic illness

Where it's running

• CMH Kharian Medical College
  Kharan, Punjab Province, Pakistan Recruiting

Study contacts

• Study coordinator: Mushayada Irshad, MBBS, MPhil Pharmacology
• Email: mishy2360@gmail.com
• Phone: +92537532239

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Treatment for Herpes Zoster Pain Using Dexmedetomidine and High Voltage Therapy

  This study is testing whether a nasal spray with dexmedetomidine, used alongside high-voltage therapy, can help people with painful herpes zoster feel better.

  Recruiting Phase 2 Zunyi Medical College · Zunyi, Guizhou · NCT06978192

• Two-dose recombinant shingles vaccine for healthy adults 40 and older

  This trial will try two doses of a recombinant shingles vaccine in healthy adults aged 40 and over to see how safe it is and whether it produces an immune response.

  Recruiting Phase 1/2 Shanghai Institute Of Biological Products · Wuhan, Hubei · NCT06932523

• Analyzing the link between shingles and vascular dementia risk

  This study is trying to see if having shingles increases the risk of developing problems with blood vessels and vascular dementia compared to people who don't have shingles.

  Recruiting at 2 sites Center for Clinical Studies, Texas · Houston, Texas and 1 other locations · NCT06903078

• Evaluating a new vaccine for shingles in adults aged 40 and older

  This study is testing a new shingles vaccine in healthy adults aged 40 and older to see if it's safe and effective.

  Recruiting Phase 1 Guangzhou Patronus Biotech Co., Ltd. · Meizhou · NCT06874842

• Evaluating the Shingrix vaccine in kidney transplant recipients

  This study tests how well the Shingrix vaccine works and its safety for people waiting for a kidney transplant.

  Recruiting at 4 sites Phase 3 University of Colorado, Denver · Aurora, Colorado and 3 other locations · NCT04128189

• Ultrasound-guided erector spinae plane block plus steroids versus usual care for post-herpetic neuralgia pain

  This study will test whether an ultrasound-guided erector spinae plane block with steroids reduces pain and improves satisfaction in adults with post-herpetic neuralgia who have not improved with medicines.

  Recruiting Alexandria University · Alexandria, Aleexandria · NCT07256145

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.